基本信息
浏览量:722
职业迁徙
个人简介
As a primary member of the BCM-HGSC faculty, I have been at the center since it was founded in 1996, when the National Human Genome Research Institute chose it for one of six pilot programs for the final phase of the Human Genome Project.
Since then I have established a long history in sequencing platform implementation and application development for human, comparative and microbial sequencing. These goals are central to the BCM-HGSC mission of advancing precision medicine through genomics which relies on a strong foundation of quality sequencing data and technology advancement. Both sequencing platform stability and production methods must be highly robust for accurate human sequencing applications. As the Director of Operations for the HGSC, my scientific interest has been the continued development of high throughput platform pipelines and applications for all elements of data generation as well as the management and operational oversight of the multidisciplinary production team required for large scale sequencing production projects. Methods include exome and regional capture hybridization, whole genome and amplicon based NexGen sequencing for variant discovery and validation. Platform development has included all major technologies including Sanger, Roche/454, Life Technologies/SOLiD, Illumina/HiSeq, Pacific Biosciences/RS and Sequel and most recently the Illumina/HiSeq X and NovaSeq platforms for high throughput Whole Genome Sequencing.
A transition of standard exome and genome methods to a clinical environment has been a major activity of the HGSC since 2011. In collaboration with the department of Molecular and Human Genetics at Baylor College of Medicine, the Whole Genome Laboratory (WGL, now Baylor Genetics) was established for the purpose of clinical exome sequencing. As Technical Director of the WGL, my interests focused on the development of exome and regional protocols for clinical sequencing applications. These efforts have included the development of clinical standards for exome coverage as well as appropriate reporting mechanisms in support of clinical interpretation. Currently, as a Director for the Human Genome Sequencing Center Clinical Laboratory (HGSC-CL), my interests have expanded in clinical assay development and clinical laboratory management to provide large scale production delivery of targeted NGS panels, exome, genome and RNASeq applications for clinical research in a CAP/CLIA environment. The combined HGSC laboratory expertise in large scale sequencing and clinical diagnostic sequencing has enabled funding in competitive NIH/NHGRI programs such as Clinical Sequencing Evidence-Generating Research (CSER), the Undiagnosed Disease Network (UDN) and the Electronic Medical Records and Genomics (eMERGE) Network.
Since then I have established a long history in sequencing platform implementation and application development for human, comparative and microbial sequencing. These goals are central to the BCM-HGSC mission of advancing precision medicine through genomics which relies on a strong foundation of quality sequencing data and technology advancement. Both sequencing platform stability and production methods must be highly robust for accurate human sequencing applications. As the Director of Operations for the HGSC, my scientific interest has been the continued development of high throughput platform pipelines and applications for all elements of data generation as well as the management and operational oversight of the multidisciplinary production team required for large scale sequencing production projects. Methods include exome and regional capture hybridization, whole genome and amplicon based NexGen sequencing for variant discovery and validation. Platform development has included all major technologies including Sanger, Roche/454, Life Technologies/SOLiD, Illumina/HiSeq, Pacific Biosciences/RS and Sequel and most recently the Illumina/HiSeq X and NovaSeq platforms for high throughput Whole Genome Sequencing.
A transition of standard exome and genome methods to a clinical environment has been a major activity of the HGSC since 2011. In collaboration with the department of Molecular and Human Genetics at Baylor College of Medicine, the Whole Genome Laboratory (WGL, now Baylor Genetics) was established for the purpose of clinical exome sequencing. As Technical Director of the WGL, my interests focused on the development of exome and regional protocols for clinical sequencing applications. These efforts have included the development of clinical standards for exome coverage as well as appropriate reporting mechanisms in support of clinical interpretation. Currently, as a Director for the Human Genome Sequencing Center Clinical Laboratory (HGSC-CL), my interests have expanded in clinical assay development and clinical laboratory management to provide large scale production delivery of targeted NGS panels, exome, genome and RNASeq applications for clinical research in a CAP/CLIA environment. The combined HGSC laboratory expertise in large scale sequencing and clinical diagnostic sequencing has enabled funding in competitive NIH/NHGRI programs such as Clinical Sequencing Evidence-Generating Research (CSER), the Undiagnosed Disease Network (UDN) and the Electronic Medical Records and Genomics (eMERGE) Network.
研究兴趣
论文共 593 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
NATURE COMMUNICATIONSno. 1 (2024): 1-15
Zeynep Coban-Akdemir,Xiaofei Song, Francisco C. Ceballos,Davut Pehlivan,Ender Karaca,Yavuz Bayram, Tadahiro Mitani,Tomasz Gambin, Tugce Bozkurt Yozgatli,Shalini N. Jhangiani,Donna M. Muzny,Richard A. Lewis,
Genetics in Medicine Open (2024): 101830
NUCLEIC ACIDS RESEARCHno. 4 (2024): e18-e18
Jianhong Hu,Viktoriya Korchina,Hana Zouk,Maegan V. Harden,David Murdock,Alyssa Macbeth,Steven M. Harrison,Niall Lennon,Christie Kovar,Adithya Balasubramanian, Lan Zhang, Gauthami Chandanavelli,
Ross Mangum,Jacquelyn Reuther,Koel Sen Baksi,Ilavarasi Gandhi, Ryan C Zabriskie,Alva Recinos,Robin Raesz-Martinez,Frank Y Lin,Samara L Potter,Andrew C Sher, Stephen F Kralik,Carrie A Mohila,
Pediatric hematology and oncologyno. 8 (2023): 1-20
bioRxiv : the preprint server for biology (2023)
Christopher M Grochowski,Jesse D Bengtsson,Haowei Du,Mira Gandhi, Ming Yin Lun,Michele G Mehaffey,KyungHee Park,Wolfram Hoeps, Eva Benito-Garagorri,Patrick Hasenfeld,Jan O Korbel,Medhat Mahmoud,
bioRxiv : the preprint server for biology (2023)
引用0浏览0WOS引用
0
0
Ronit Marom,Bo Zhang,Megan E. Washington,I-Wen Song,Lindsay C. Burrage, Vittoria C. Rossi, Ava S. Berrier,Anika Lindsey, Jacob Lesinski,Michael L. Nonet,Jian Chen,Dustin Baldridge,
PLoS geneticsno. 11 (2023): e1011005-e1011005
引用0浏览0WOS引用
0
0
Science Advancesno. 17 (2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn